Development of intimate contact during processing of carbon fiber reinforced Polyamide-6 tapes

Contact development between the surfaces of two tapes is considered as a critical step in processing carbon fiber reinforced thermoplastic composites. In this study, the development of intimate contact between carbon fiber reinforced Polyamide-6 (PA-6) tapes is investigated experimentally using consolidation experiments and X-ray computed tomography for quantitative contact characterization. The experimental results indicate that the development of intimate contact occurs in the range of seconds even when temperatures are only slightly above the melting temperature and applied pressures is in the range of 1-4 kPa. Experimental data are compared with the results of the two analytical models proposed by Lee and Springer as well as Yang and Pitchumani. Both models overestimate the time needed to reach full contact for the PA-6 tape. In comparison to previously investigated PEEK materials, PA-6 has a relatively low viscosity and the tapes possess a resin-rich layer near the surface, which seems to influence the contact development process. Besides the assumptions made for viscosity, the sensitivity to input parameters describing the surface topology strongly influence the model results and the accuracy of predictions. </jats:p

Localization of a continuous CO2 leak from an isotropic flat-surface structure using acoustic emission detection and near-field beamforming techniques

Seal capacity is of great importance for the safety operation of pressurized vessels. It is crucial to locate the leak hole timely and accurately for reasons of safety and maintenance. This paper presents the principle and application of a linear acoustic emission sensor array and a near-field beamforming technique to identify the location of a continuous CO2 leak from an isotropic flat-surface structure on a pressurized vessel in the Carbon Capture and Storage system. Acoustic signals generated by the leak hole are collected using a linear high-frequency sensor array. Time-frequency analysis and a narrow-band filtering technique are deployed to extract effective information about the leak. The impacts of various factors on the performance of the localization technique are simulated, compared and discussed, including the number of sensors, distance between the leak hole and sensor array and spacing between adjacent sensors. Experiments were carried out on a laboratory-scale test rig to assess the effectiveness and operability of the proposed method. The results obtained suggest that the proposed method is capable of providing accurate and reliable localization of a continuous CO2 leak

Induction chemotherapy followed by concurrent standard radiotherapy and daily low-dose cisplatin in locally advanced non-small-cell lung cancer

Both induction chemotherapy and concurrent low-dose cisplatin have been shown to improve results of thoracic irradiation in the treatment of locally advanced non-small-cell lung cancer (NSCLC). This phase II study was designed to investigate activity and feasibility of a novel chemoradiation regimen consisting of induction chemotherapy followed by standard radiotherapy and concurrent daily low-dose cisplatin. Previously untreated patients with histologically/cytologically proven unresectable stage IIIA/B NSCLC were eligible. Induction chemotherapy consisted of vinblastine 5 mg m−2 intravenously (i.v.) on days 1, 8, 15, 22 and 29, and cisplatin 100 mg m−2 i.v. on days 1 and 22 followed by continuous radiotherapy (60 Gy in 30 fractions) given concurrently with daily cisplatin at a dose of 5 mg m−2 i.v. Thirty-two patients were enrolled. Major toxicity during induction chemotherapy was haematological: grade III–IV leukopenia was observed in 31% and grade II anaemia in 16% of the patients. The most common severe toxicity during concurrent chemoradiation consisted of grade III leukopenia (21% of the patients); grade III oesophagitis occurred in only two patients and pulmonary toxicity in one patient who died of this complication. Eighteen of 32 patients (56%, 95% CI 38–73%) had a major response (11 partial response, seven complete response). With a median follow-up of 38.4 months, the median survival was 12.5 months and the actuarial survival rates at 1, 2 and 3 years were 52%, 26% and 19% respectively. The median event-free survival was 8.3 months with a probability of 40%, 23% and 20% at 1, 2 and 3 years respectively. Induction chemotherapy followed by concurrent daily low-dose cisplatin and thoracic irradiation, in patients with locally advanced NSCLC, is active and feasible with minimal non-haematological toxicity. Long-term survival results are promising and appear to be similar to those of more toxic chemoradiation regimens, warranting further testing of this novel chemoradiation strategy. © 1999 Cancer Research Campaig

How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer

The trimodality approach represented by concurrent chemoradiotherapy followed by surgical resection is a highly effective, but potentially toxic therapy for locally advanced non-small-cell lung cancer (NSCLC). In this review, we discuss the current status of this therapy in patients with mediastinal node-positive (N2) stage III NSCLC or superior sulcus tumor, and present an overview of the principles for optimisation of the risk/benefit. Numerous clinical questions remain, and enrolment of patients into well-designed clinical trials should be encouraged

Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer

The role of new cytotoxic agents like gemcitabine has not yet been proven in the neoadjuvant settings. We designed a phase II study to test the feasibility of using gemcitabine and cisplatin before local treatment for stage III non-small cell lung cancer patients. Patients received three cycles of induction chemotherapy of gemcitabine (1000 mg m−2, days 1, 8, 15) and cisplatin (90 mg m−2, day 15) every 4 weeks before evaluation for operability. Operable patients underwent radical resection. Inoperable patients and patients who had incomplete resection received concurrent chemoradiotherapy with daily low dose cisplatin. All patients who did not progress after local treatment received three more cycles of adjuvant chemotherapy of gemcitabine and cisplatin. Fifty-two patients received induction treatment. Two patients had complete response and 31 patients had partial response (response rate 63.5%) after induction chemotherapy. Thirty-six patients (69%) were operable. Eighteen patients (35%) had their tumours completely resected. Two patients had pathological complete response. Median overall survival was 19.1 months, projected 1-year survival was 66% and 2-year survival was 34%. Three cycles of gemcitabine and cisplatin is effective and can be used as induction treatment before surgery for locally advanced non-small cell lung cancer patients